Medicover AB Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	109.1	98.4	20.1
Depreciation & Amortization	220.4	215.3	214.6
Stock-Based Compensation	13.5	15.4	12.2
Other Adjustments	33	19.7	33
Change in Receivables	-56.6	-53.4	-53.3
Changes in Inventories	-8.1	-1	-8.2
Changes in Accounts Payable	33.9	49.3	43.5
Changes in Other Operating Activities	7.9	-	-
Operating Cash Flow	345.2	343.7	261.9
Operating Cash Flow Growth	22.72%	31.23%	-
Purchases of Intangible Assets	-158.9	-158.1	-122.3
Proceeds from Sale of Intangible Assets	1.2	1	2.2
Purchases of Investments	-2.6	-16	-25.6
Proceeds from Sale of Investments	4.4	18.6	23.3
Cash Acquisitions	-4.8	-174.6	-18.1
Proceeds from Business Divestments	0.4	3	0.1
Other Investing Activities	4	4	5.7
Investing Cash Flow	-156.3	-322.1	-134.7
Long-Term Debt Issued	853.2	945.2	884.8
Long-Term Debt Repaid	-925.3	-859.1	-829.2
Net Long-Term Debt Issued (Repaid)	-72.1	86.1	55.6
Common Dividends Paid	-30.2	-22.5	-18
Other Financing Activities	-71.8	-69.4	-145.6
Financing Cash Flow	-174.1	-5.8	-108
Foreign Exchange Rate Adjustments	-1.5	-3.3	-0.2
Net Cash Flow	14.8	15.8	19.2
Free Cash Flow	345.2	343.7	261.9
Free Cash Flow Growth	22.72%	31.23%	-
FCF Margin	13.99%	14.45%	12.52%
Free Cash Flow Per Share	2.28	2.28	1.74
Levered Free Cash Flow	266.9	427.2	322.2
Unlevered Free Cash Flow	383.73	378.63	300.96